NeuroMetrix Q2 EPS $(0.74) Up From $(1.52) YoY, Sales $769,148 Down From $1.65M YoY
Portfolio Pulse from Benzinga Newsdesk
NeuroMetrix (NASDAQ:NURO) reported Q2 EPS of $(0.74), an improvement from $(1.52) YoY, but sales plummeted to $769,148 from $1.65M YoY.
August 06, 2024 | 11:09 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
NeuroMetrix reported a significant improvement in EPS for Q2, but experienced a drastic decline in sales. EPS improved to $(0.74) from $(1.52) YoY, while sales fell to $769,148 from $1.65M YoY.
While the improvement in EPS is a positive sign, the drastic decline in sales is concerning and likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100